Literature DB >> 30023978

Where do these guests come from? A diagnostic approach for metastatic lymph nodes.

Yelda Dere1, Sümeyye Ekmekçi2, Serkan Çelik1, Özgür İlhan Çelik1, Özcan Dere3, Volkan Karakuş4.   

Abstract

OBJECTIVE: In cases presenting with lymphadenopathies (LAP) without a primary focus detected by simple radiological methods, the primary tumor can be diagnosed by a histopathological evaluation of the metastatic lymph nodes. We aimed to discuss the nonhematological malignancies presenting with lymphadenopathies and the histopathological results for primary tumors.
MATERIAL AND METHODS: In this retrospective study, cases diagnosed with metastasis in excisional lymph nodes between January 2013 and June 2016 were assessed for a histopathological diagnostic approach.
RESULTS: Among 632 lymph node biopsies, a total of 21 cases, involving 12 male and 9 female patients with a mean age of 57.23 y (range, 33-92 y), of nonhematological solid tumors were included. The most common localizations of the involved lymph nodes were inguinal (n=8), axillary (n=6), cervical (n=4), and supraclavicular (n=3) region. The most common primary tumors were malignant melanoma (n=6), breast carcinoma (n=4), ovarian carcinoma (n=2), squamous cell carcinoma (n=2), and germ cell tumor (n=2). Others were papillary thyroid carcinoma, renal cell carcinoma, urothelial carcinoma, prostate adenocarcinoma, and endometrial adenocarcinoma.
CONCLUSION: Nonhematological malignancies presenting with lymphadenopathies are one of the most complicated cases for clinicians. The histopathological evaluation of the excisional metastatic lymph node biopsies is an important method because of cost effectiveness and easy applicability.

Entities:  

Keywords:  Immunohistochemistry; lymph node metastasis; unknown primary tumor

Year:  2018        PMID: 30023978      PMCID: PMC6048636          DOI: 10.5152/turkjsurg.2018.3856

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  15 in total

Review 1.  Microarrays--chances and challenges.

Authors:  C P Pilarsky; A O Schmitt; E Dahl; A Rosenthal
Journal:  Curr Opin Mol Ther       Date:  1999-12

Review 2.  Metastases of undetermined source.

Authors:  E T Krementz; E J Cerise; D S Foster; L R Morgan
Journal:  Curr Probl Cancer       Date:  1979-11       Impact factor: 3.187

Review 3.  Immunocytodiagnosis of solid tumors employing panels of monoclonal antibodies.

Authors:  M Mottolese; I Venturo; M Salzano; M Benevolo; A Bigotti; P G Natali
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

4.  Breast MR imaging in patients with axillary node metastases and unknown primary malignancy.

Authors:  S G Orel; S P Weinstein; M D Schnall; C A Reynolds; L M Schuchter; D L Fraker; L J Solin
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

Review 5.  Unknown primary tumors.

Authors:  C Natoli; V Ramazzotti; O Nappi; P Giacomini; S Palmeri; M Salvatore; M Landriscina; M Zilli; P G Natali; N Tinari; S Iacobelli
Journal:  Biochim Biophys Acta       Date:  2011-03-01

6.  Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Authors:  Russell Vang; Allen M Gown; Lee-Shu-Fune Wu; Todd S Barry; Darren T Wheeler; Anna Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

Review 7.  The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.

Authors:  Pascal Sève; Claire Billotey; Christiane Broussolle; Charles Dumontet; John R Mackey
Journal:  Cancer       Date:  2007-01-15       Impact factor: 6.860

8.  Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia cases.

Authors:  Heiner Adams; Patrik Schmid; Stephan Dirnhofer; Alexandar Tzankov
Journal:  Pathol Res Pract       Date:  2008-04-23       Impact factor: 3.250

9.  Switching benchmarks in cancer of unknown primary: from autopsy to microarray.

Authors:  George Pentheroudakis; Vassilios Golfinopoulos; Nicholas Pavlidis
Journal:  Eur J Cancer       Date:  2007-08-14       Impact factor: 9.162

10.  Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

Authors:  J L Abbruzzese; M C Abbruzzese; R Lenzi; K R Hess; M N Raber
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.